The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Impact of subanesthetic doses of ketamine on AMPA-mediated responses in rats: An in vivo electrophysiological study on monoaminergic and glutamatergic neurons
Open accessAbstract
The rapid antidepressant action of a subanesthetic dose of ketamine in treatment-resistant patients represents the most striking recent breakthrough in the understanding of the antidepressant response. Evidence demonstrates tight interactions between the glutamatergic and monoaminergic systems. It is thus hypothesized that monoamine systems may play a role in the immediate/rapid effects of ketamine. In vivo electrophysiological recordings were carried in male rats following ketamine administration (10 and 25 mg/kg, i.p.) to first assess its effects on monoaminergic neuron firing. In a second series of experiments, the effects of ketamine administration on α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)- and N-methyl-D-aspartate receptor (NMDA)-evoked responses in hippocampus CA3 pyramidal neurons were also investigated using micro-iontophoretic applications. Although acute (~2 hours) ketamine administration did not affect the mean firing activity of dorsal raphe serotonin and ventral tegmental area dopamine neurons, it did increase that of locus coeruleus norepinephrine neurons. In the latter brain region, while ketamine also enhanced bursting activity, it did increase population activity of dopamine neurons in the ventral tegmental area. These effects of ketamine were prevented by the prior administration of the AMPA receptor antagonist 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[ f]quinoxaline-7-sulfonamide. An increase in AMPA-evoked response of CA3 pyramidal neurons was also observed 30 minutes following acute ketamine administration. The present findings suggest that acute ketamine administration produces a rapid enhancement of catecholaminergic neurons firing activity through an amplification of AMPA transmission. These effects may play a crucial role in the antidepressant effects of ketamine observed shortly following its infusion in depressed patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Brexpiprazole, a partial dopamine D2 and 5-hydroxytryptamine 1A (5-HT1A) agonist with 5-hydroxytryptamine 2A (5-HT2A) antagonism, facilitates AMPAR-mediated transmission in medial prefrontal cortex through a dopamine D1-dependent cascade, particularly when combined with selective serotonin reuptake inhibitors (SSRIs) such as escitalopram [384].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [384]
Experimental — accuracy not yet measuredIn the citing paper
“Ketamine administration was also shown to enhance AMPA-evoked electrophysiological responses in the rat hippocampus and medial PFC, suggesting that ketamine may augment AMPA receptor transmission.99,100”
From Ketamine as an antidepressant: Overview of its mechanisms of action and potential predictive biomarkers (2020) · cites this paper as [99]
In the citing paper
“In fact, low doses of ketamine were shown to induce an enhancement of AMPAR-mediated synaptic transmission in the mPFC 145 and hippocampus 146 of rats, as measured by AMPAR currents in pyramidal neurons and extracellular in vivo electrophysiological recordings in CA3 pyramidal neurons respectively.”
From Mechanisms of ketamine action as an antidepressant (2018) · cites this paper as [146]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,831 · cited 1×
“A burr hole was drilled at the stereotaxic coordinates corresponding to the brain structure of interest (Paxinos and Watson, 2007).”
MethodMolecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856 · cited 1×
“Significant improvement in depressive symptoms occurred within 72 hours following infusion of ketamine in seven subjects in the first placebo-controlled double-blind study (Berman et al., 2000).”
BackgroundInfluentialA randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766 · cited 1×
“This was replicated in a larger double-blind study (Zarate et al., 2006).”
ResultmTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881 · cited 10×
“In the case where 10 mg/kg (Li et al., 2010) did not induce any effect, 25 mg/kg dose of ketamine was used as in Gigliucci et al. (2013); at this dose, ketamine is still subanesthetic and produces a significant effect in the FST model (Li et al., 2010; Gigliucci et al., 2013).”
BackgroundMethodInfluentialDrevets, W. C., Price, J. L., & Furey, M. L. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0189-x · Cited by 2,241 · cited 1×
“Due to its pivotal role in neurocircuitry involved in major depression (see Drevets et al. 2008) and in light of studies showing neuronal plasticity following ketamine administration (see Kavalali and Monteggia, 2012), the hippocampus was selected to assess whether the responsiveness of CA3…”
BackgroundNMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926 · cited 2×
“Furthermore, while Li et al. (2010) showed that pre-administration of rapamycin blocked the ketamine-mediated decrease in immobility time in the forced swim test (FST), investigations by Autry et al. (2011) revealed that rapamycin failed to reverse such an effect.”
BackgroundMoghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793 · cited 4×
“**p < 0.01; *p < 0.05. ketamine (Lorrain et al., 2003a; Moghaddam et al., 1997) would have increased firing activity of 5-HT neurons through AMPA receptors.”
BackgroundInfluentialHomayoun, H., & Moghaddam, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2213-07.2007 · Cited by 1,231 · cited 2×
“Indeed, blockade by MK-801 of NMDA receptors located on GABA neurons leads to decreased inhibition (disinhibition) following a surge in glutamate, thus resulting in an enhancement of AMPA activation (Abdallah et al., 2014; Homayoun and Moghaddam, 2007).”
Background
Research works printed but not linked: 1
- Abdallah CG, 2014, Annu Rev Med, 25341010
Cited by
Mechanisms of ketamine action as an antidepressant
Zanos, P., & Gould, T. D. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.255 · Cited by 1,127
Kokkinou, M., Ashok, A. H., & Howes, O. D. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.190 · Cited by 247
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232
Aleksandrova, L. R., Phillips, A. G., & Wang, Y. T. (2017) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.160175 · Cited by 228
Matveychuk, D., Thomas, R. K., Swainson, J., Khullar, A., MacKay, M.-A., Baker, G. B., & Dursun, S. M. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320916657 · Cited by 209
Metadata
- Authors
- El Iskandrani, K. S., Oosterhof, C. A., El Mansari, M., & Blier, P.
- Affiliations
- University of Ottawa Institute of Mental Health Research, Mood Disorders Research, Ottawa, ON, Canada
- University of Ottawa (CA)
- ORCID
- Blier, Pierre
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2015-03-10
- Volume
- 29
- Issue
- 7
- Pages
- 792-801
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- PMC
- PMC4469544
- OpenAlex
- W2064513288
- Cited by
- 75
- References
- 56
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 5 · 2023: 8 · 2022: 4 · 2021: 3 · 2020: 7 · 2019: 10 · 2018: 8 · 2017: 9 · 2016: 5
- FWCI
- 5.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- University of Ottawa
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- ketamine, subanesthetic doses, rapid antidepressant effects, AMPA receptors, NMDA receptor, locus coeruleus, noradrenergic neurons, ventral tegmental area, dopaminergic neurons, dorsal raphe nucleus, serotonergic neurons, CA3 pyramidal cells, hippocampus, AMPA receptor antagonists, treatment-resistant depression
- MeSH terms
- Animals, Antidepressive Agents, Brain, Dose-Response Relationship, Drug, Hippocampus, Ketamine, Male, Neurons, Quinoxalines, Receptors, N-Methyl-D-Aspartate, Rats, Sprague-Dawley, Receptors, AMPA, Excitatory Amino Acid Antagonists, Rats, Electrophysiological Phenomena, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of subanesthetic doses of ketamine on AMPA-mediated responses in rats: An in vivo electrophysiological study on monoaminergic and glutamatergic neurons. https://app.cochat.ai/papers/10.1177/0269881115573809
- The paper
- El Iskandrani, K. S., Oosterhof, C. A., El Mansari, M., & Blier, P. (2015). Impact of subanesthetic doses of ketamine on AMPA-mediated responses in rats: An in vivo electrophysiological study on monoaminergic and glutamatergic neurons. Journal of Psychopharmacology. https://doi.org/10.1177/0269881115573809
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.